RESTRICTED AREA
* The information contained on this page is intended for veterinarians or animal health professionals with the ability to prescribe and/or dispense medicines.If you meet these requirements, talk to our sales department.
Ref.: HH 00 918
VACSINCEL 100ML 50DS
Gonadotropin Releasing Factor Analog Protein Conjugate
If you have already registered, log in to GirovetPro
Description
PHARMACEUTICAL FORM
Injectable solution. Clear, colorless or yellowish viscous solution.
TARGET SPECIES
Extensively raised sows (18 weeks old).
Injectable solution. Clear, colorless or yellowish viscous solution.
TARGET SPECIES
Extensively raised sows (18 weeks old).
Indications
Induction of antibodies against GnRF to produce a temporary immunological suppression of ovarian function. Indicated as an alternative to physical castration, preventing sows from reaching puberty.
- Establishment of immunity (induction of anti-GnRF antibodies): may appear 2 weeks after the second dose.
- Duration of immunity: to maintain the anti-GnRF antibody level until slaughter (14 months), administer a third dose 12 weeks after the second dose and a fourth dose 12 weeks after the third dose.
Dose / Application / Administration
Routes of administration:
Subcutaneously.
Dosage:
Immunize sows at 18 weeks of age with 4 doses of 2 ml with an interval of 4 weeks between the first two and an interval of 12 weeks between the second and third doses. To maintain heat suppression until slaughter (14 months), administer a fourth dose 12 weeks after the third.
Administer the veterinary medicinal product by subcutaneous injection in the neck, just behind the ear, using a double safety vaccination gun with a short needle penetrating 19mm. Depending on the size and shape of the bristles, needles of greater or lesser length and depth of penetration may be needed.
Subcutaneously.
Dosage:
Immunize sows at 18 weeks of age with 4 doses of 2 ml with an interval of 4 weeks between the first two and an interval of 12 weeks between the second and third doses. To maintain heat suppression until slaughter (14 months), administer a fourth dose 12 weeks after the third.
Administer the veterinary medicinal product by subcutaneous injection in the neck, just behind the ear, using a double safety vaccination gun with a short needle penetrating 19mm. Depending on the size and shape of the bristles, needles of greater or lesser length and depth of penetration may be needed.
Composition
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 2 ml dose contains:
Active substance:
Gonadotropin-Releasing Factor Analogue Protein Conjugate (GnRF) (synthetic GnRF analog peptide conjugated to diphtheria toxoid): ≥ 300 μg
Adjuvant:
Diethylaminoethyl (DEAE)-Dextran, non-mineral oil-based aqueous adjuvant: 300mg
Excipients:
Chlorocresol: 2.0mg
Each 2 ml dose contains:
Active substance:
Gonadotropin-Releasing Factor Analogue Protein Conjugate (GnRF) (synthetic GnRF analog peptide conjugated to diphtheria toxoid): ≥ 300 μg
Adjuvant:
Diethylaminoethyl (DEAE)-Dextran, non-mineral oil-based aqueous adjuvant: 300mg
Excipients:
Chlorocresol: 2.0mg
Presentation
100 ml
Laboratory
ZOETIS
Leave us your comment